Here are five reasons why:
1. October tends to see more volatility in the broader market.
2. There are big healthcare and biotech conferences in October, in addition to analyst meetings.
3. October brings another earnings report, which could signal turbulence.
4. The upcoming presidential debates ahead of the election could affect the healthcare space, as healthcare is one of the big issues in the election. Regardless of who wins the presidency, there will likely be changes in the healthcare sector within the first 100 days of the new presidency, which could affect healthcare companies’ pricing power.
5. There is public dissatisfaction with pharmaceutical prices today. Sudden price increases, including those for EpiPen most recently, have come under fire.
More articles on healthcare:
5 things to know on CMS emergency preparedness final rule for ASCs
The changing nature of physician ownership—5 things to know
Molina Healthcare is the ACA’s latest success story: 6 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
